Cardiomyopathy with prominent autophagic degeneration accompanied by an elevated plasma brain natriuretic peptide level despite the lack of overt heart failure

Internal Medicine

Volumn 43, Issue 8, 2004, Pages 700-703

  Saijo, Mieko ^a   Takemura, Genzou ^a   Koda, Masahiko ^a   Okada, Hideshi ^a   Miyata, Shusaku ^a   Ohno, Yasushi ^a   Kawasaki, Masanori ^a   Tsuchiya, Kunihiko ^a   Nishigaki, Kazuhiko ^a   Minatoguchi, Shinya ^a   Goto, Koshi ^a   Fujiwara, Hisayoshi ^a  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Autophagy; BNP; Myocardial disease

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CARVEDILOL; ENALAPRIL; GLYCOGEN; LIPOFUSCIN; MYELIN;

AGED; ARTICLE; AUTOPHAGY; CARDIOMYOPATHY; CASE REPORT; CELL DEGENERATION; CELL GRANULE; CELL ULTRASTRUCTURE; CELL VACUOLE; CYTOCHEMISTRY; CYTOPLASM; DEGRADATION; DISEASE CLASSIFICATION; HEART FAILURE; HEART LEFT VENTRICLE; HEART MUSCLE BIOPSY; HEART MUSCLE CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREACTIVITY; MALE; MITOCHONDRION; MUSCLE FIBRIL; PHAGOSOME;

AGED; AUTOPHAGY; BIOPSY; CARDIOMYOPATHIES; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MYOCARDIUM; NATRIURETIC PEPTIDE, BRAIN;

EID: 4644335455     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.43.700     Document Type: Article

References (16)

1. Klionsky DJ, Emr SD. Autophagy as a regulated pathway of cellular degradation. Science 290: 1717-1721, 2000.
2. Danon MJ, Oh SJ, DiMauro S, et al. Lysosomal glycogen storage disease with normal acid maltase. Neurology 31: 51-57, 1981.
3. Tanaka Y, Guhde G, Suter A, et al. Accumulation of autophagic vacuoles and cardiomyopathy in LAMP-2-deficient mice. Nature 406: 902-906, 2000.
4. Nishino I, Fu J, Tanji K, et al. Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease). Nature 406: 906-910, 2000.
5. Shimomura H, Terasaki F, Hayashi T, Kitaura Y, Isomura T, Suma H. Autophagic degeneration as a possible mechanism of myocardial cell death in dilated cardiomyopathy. Jpn Circ J 65: 965-968, 2001.
6. Knaapen MW, Davies MJ, De Bie M, Haven AJ, Martinet W, Kockx MM. Apoptotic versus autophagic cell death in heart failure. Cardiovasc Res 51: 304-312, 2001.
7. Hein S, Arnon E, Kostin S, et al. Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms. Circulation 107: 984-991, 2003.
8. Hasegawa K, Fujiwara H, Doyama K, e al. Ventricular expression of brain natriuretic peptide in hypertrophic cardiomyopathy. Circulation 88: 372-380, 1993.
9. Maron BJ, Ferrans VJ, Roberts WC. Ultrastructural features of degenerated cardiac muscle cells in patients with cardiac hypertrophy. Am J Pathol 79: 387-434, 1975.
10. Baandrup U, Florio RA, Roters F, Olsen EG. Electron microscopic investigation of endomyocardial biopsy samples in hypertrophy and cardiomyopathy. A semiquantitative study in 48 patients. Circulation 63: 1289-1298, 1981.
11. Bordiuk JM, Legato MJ, Lovelace RE, Blumenthal S. Pompe's disease. Electromyographic, electron microscopic, and cardiovascular aspects. Arch Neurol 23: 113-119, 1970.
12. Mukoyama M, Nakao K, Hosoda K, et al. Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest 87: 1402-1412, 1991.
13. Horie H, Tsutamoto, T, Ishimoto N, et al. Plasma brain natriuretic peptide as a biochemical marker for atrioventricular sequence in patients with pacemakers. Pacing Clin Electrophysiol 22: 282-290, 1999.
14. Takemura G, Takatsu Y, Doyama K, et al. Expression of atrial and brain natriuretic peptides and their genes in hearts of patients with cardiac amyloidosis. J Am Coll Cardiol 31: 754-765, 1998.
15. Tokola H, Hautala N, Marttila M, et al. Mechanical load-induced alterations in B-type natriuretic peptide gene expression. Can J Physiol Pharmacol 79: 646-653, 2001.
16. Bloch KD, Seidman JG, Naftilan JD, Fallon JT, Seidman CE. Neonatal atria and ventricles secrete atrial natriuretic factor via tissue-specific secretory pathways. Cell 47: 695-702, 1986.